Cargando…
Activation of transient receptor potential channel Sm.(Schistosoma mansoni)TRPM(PZQ) by PZQ, enhanced Ca(++) influx, spastic paralysis, and tegumental disrupture—the deadly cascade in parasitic schistosomes, other trematodes, and cestodes
After almost 50 years of praziquantel (PZQ) research, Park and Marchant (Trends Parasitol 36:182–194, 2020) described the Ca(++)-permeable transient receptor potential (TRP) channel Sm.TRPM(PZQ) in Schistosoma mansoni as target of PZQ. Here we describe the deadly cascade in schistosomes which is ind...
Autor principal: | Harder, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366562/ https://www.ncbi.nlm.nih.gov/pubmed/32607709 http://dx.doi.org/10.1007/s00436-020-06763-8 |
Ejemplares similares
-
Morphological Characteristics of Schistosoma mansoni PZQ-Resistant and -Susceptible Strains Are Different in Presence of Praziquantel
por: Pinto-Almeida, António, et al.
Publicado: (2016) -
Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study
por: Mahende, Muhidin K., et al.
Publicado: (2021) -
PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?
por: Aruleba, Raphael Taiwo, et al.
Publicado: (2019) -
The Anthelmintic
Activity of Praziquantel Analogs
Correlates with Structure–Activity Relationships at TRPM(PZQ) Orthologs
por: Sprague, Daniel J., et al.
Publicado: (2023) -
Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis
por: Bustinduy, Amaya L., et al.
Publicado: (2016)